Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Stl 426.60 1.32
Hindalco 144.70 0.00
Bhel 189.30 1.42
Larsen & 1377.30 2.48
Wipro Lt 525.00 1.19
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Sharon Bio-Medicine Limited
Sharon Bio-Medicine Limited
Sector:Pharmaceuticals Pharmaceuticals - Pharmaceuticals - Others
BSE:532908NSE:SHARONBIOBloomberg:SBML@INReuters:SHBM.BO
Market Lot: 1Face Value: 2ISIN Demat: INE028B01029
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
12-JUN-13 Sharon Bio-Medicine announced that company's Toxicology Laboratory namely SA-FORD, which is approved by Organisation of Economic Development and Cooperation (OECD) countries has also got the approval from SENASA a Toxicology approval authority of Govt of Argentina. 13-FEB-12 Sharon Bio-Medicine has announced that it has filed its ANDA for Memantine Hydrochloride Tablets, 5 mg and 10 mg tablets from its drug product manufacturing fac...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Sharon Bio-Medicine's toxicology lab gets approval in Argentina  -IRIS 12-Jun-13
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2013(6)30-Jun-2013 (12)30-Jun-2012 (12)
Net sales 6513.2510594.977857.29
Other Income3.968.879.13
Total Income6517.2110603.847866.42
Cost of goods sold5777.729393.876916.45
OPBDIT739.491209.97949.97
PAT314.25541.90429.86
Gross Block---
Equity capital105.57105.57105.57
EPS (Rs.)-49.1439.41
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-6.61 - 9.364.87 - 11.65
Debt / Equity (x)---
Operating margin (% of OI)11.311.412.1
Net margin (% of OI) 4.8 5.1 5.5
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Plot No W-34, W-34/ 1
MIDC, Taloja
Raigad
Maharashtra-410 208
PHONE
(022) 6513 2070/ 71
FAX
(022) 2741 1394
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer